Select for export Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_282 PubMed 34811715 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Agin-Liebes G, Davis AK. Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-05991-9 PubMed 34613430 Copy citation Copy BibTeX Unknown journal 2021-10-05 Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H. Europe PMC Published psilocybin AnxietyBrain ImagingDefault Mode Network Other More
Select for export The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.739053 PubMed 34658876 Copy citation Copy BibTeX Unknown journal 2021-09-28 Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M. Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyAging Meta-Analysis More
Select for export Rediscovering Psilocybin as an Antidepressive Treatment Strategy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph14100985 PubMed 34681209 Copy citation Copy BibTeX Unknown journal 2021-09-27 Zeiss R, Gahr M, Graf H. Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Review Article More
Select for export The therapeutical role of psychedelic drugs in treatment of mental disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.36219/bpi.2021.3.09 Copy citation Copy BibTeX Bulletin of Integrative Psychiatry 2021-09-14 Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Blinding and expectancy confounds in psychedelic randomized controlled trials. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17512433.2021.1933434 PubMed 34038314 Copy citation Copy BibTeX Unknown journal 2021-08-25 Muthukumaraswamy SD, Forsyth A, Lumley T. Europe PMC Published psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.20944/preprints202106.0682.v1 Copy citation Copy BibTeX Preprints.org 2021-06-27 Coppola M, Bevione F, Mondola R. Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin: the magic medicine for depression? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2021-06-17 Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
Select for export Psilocybin: the magic medicine for depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2021.456 Copy citation Copy BibTeX BJPsych Open 2021-05-31 Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft OpenAlex Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
Select for export Registered clinical studies investigating psychedelic drugs for psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpsychires.2021.05.019 PubMed 34048997 Copy citation Copy BibTeX Unknown journal 2021-05-17 Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Cannabis-induced oceanic boundlessness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881121997099 PubMed 33779383 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-03-27 Earleywine M, Ueno LF, Mian MN, Altman BR. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/q2hzm Copy citation Copy BibTeX PsyArXiv 2021-03-07 Muthukumaraswamy S, Forsyth A, Lumley T. PsyArXiv PREPRINT (not peer reviewed) psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2021-03-07 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.640241 PubMed 33716753 Copy citation Copy BibTeX Frontiers in Pharmacology 2021-02-25 Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S Europe PMC Published psilocybinpsilocin DepressionAnimal Study Animal Study More
Select for export Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-020-05719-1 PubMed 33427944 Copy citation Copy BibTeX Unknown journal 2021-01-10 Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D Europe PMC Published psilocybin DepressionReceptor PharmacologyClinical Trial Randomized Controlled Trial More
Select for export Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.707057 PubMed 34456763 Copy citation Copy BibTeX Frontiers in psychiatry 2020-12-31 Eleftheriou ME, Thomas E PubMed Published psilocybin DepressionMechanism of ActionWellbeing Other More
Select for export [Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?] Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.encep.2020.08.006 PubMed 33190819 Copy citation Copy BibTeX Unknown journal 2020-11-11 Bottemanne H, Claret A, Fossati P. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Other More
Select for export Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s003329172000389x PubMed 33143790 Copy citation Copy BibTeX Unknown journal 2020-11-03 Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z Europe PMC Published psilocybin Personality ChangeSpiritualityRandomized Controlled Trial Randomized Controlled Trial More
Select for export Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2020-10-19 NYU Langone Health ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyChronic Pain Review Article More
Select for export Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120959609 PubMed 33501857 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-10-07 Dea Siggaard Stenbæk, M. Madsen, Brice Ozenne, Sara Kristiansen, Daniel Burmester, David Erritzøe OpenAlex Published psilocybin Chronic PainReceptor PharmacologyConsciousness Other More
